Abstract 558: M6123, a selective FGFR1 antagonist, demonstrates anti-tumor activity as monotherapy and in combination with chemotherapy in mesothelioma models - KIVIRID

Abstract 558: M6123, a selective FGFR1 antagonist, demonstrates anti-tumor activity as monotherapy and in combination with chemotherapy in mesothelioma models

Authors: Christina Esdar, Edith Ross, Michael Sanderson, Astrid Zimmermann

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-558

Source: Full article

Abstract

Abstract